Differential diagnosis of psychotropic side effects and symptoms and signs of psychiatric disorders

Psychiatria Danubina

Volumn 21, Issue 4, 2009, Pages 570-574

  Mihanović, Mate ^a   Bodor, Davor ^a   Kezić, Slobodanka ^a   Restek Petrović, Branka ^a   Silić, Ante ^a  

^a Zagreb Fakultet za dentalnu medicinu i zdravstvo Osijek Zdravstveno veleu ili te Zagreb   (Croatia)

Author keywords

Physical sign; Psychiatric disorder; Psychopatological phenomena; Psychotropic medication; Side effect

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CHLORPROMAZINE; CLOZAPINE; GABAPENTIN; NEUROLEPTIC AGENT; OLANZAPINE; PSYCHOTROPIC AGENT; TOPIRAMATE;

AGITATION; AKATHISIA; ANTICHOLINERGIC EFFECT; CLINICAL EVALUATION; CLINICAL FEATURE; CLINICAL PRACTICE; CONFERENCE PAPER; DELIRIUM; DEPRESSION; DIABETES MELLITUS; DIFFERENTIAL DIAGNOSIS; DYSTONIA; HUMAN; HYPERGLYCEMIA; HYPERSALIVATION; MENTAL DISEASE; MYOCARDITIS; PARKINSONISM; PHYSICAL DISEASE BY BODY FUNCTION; PSYCHOPHARMACOTHERAPY; SIDE EFFECT; TARDIVE DYSKINESIA; WITHDRAWAL SYNDROME;

DIAGNOSIS, DIFFERENTIAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MENTAL DISORDERS; NEUROTOXICITY SYNDROMES; PSYCHOTROPIC DRUGS;

EID: 72849141330     PISSN: 03535053     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (28)

1. Alvarez-Jimenez M, Gonzalez-Blanch C, Crespo-Facorro B, Hetrick S, Rodriguez-Sanchez JM, Pérez-Iglesias R & Vasquez-Barquero JL: Antipsychotic-Induced Weight Gain in Chronic and First-Episode Psychotic Disorders: A Systematic Critical Reappraosal. CNS Drugs 2008; 22:547-562 (Pubitemid 351822117)
2. Anonimno. Lani prijavljeno rekordnih 1680 nuspojava lijekova. Vjesnik 2009. Sept 7; 7.
3. Aronson JA (ed): Meyler's Side Effects of Psychiatric Drugs, Elsevier, Amsterdam, 2009.
4. Ashton H: Benzodiazepine dependence. In Haddad P, Dursun S & Deadin B (eds): Adverse syndromes and psychiatric drugs. 239-259 Oxford University Press, Oxford, 2007.
5. Barnhart WJ, Makela EH, Latocha MJ: SSRI-induced apathy syndrome: A clinical review. Journal of Psychiatric Practice 2004; 10:196-199 (Pubitemid 38669730)
6. Degrandpre R: The Cult of Pharmacology. How America Became the World's Most Troubled Drug Culture. Duke University Press, Durham-London, 2006.
7. Francetić I, Huić M: Nuspojave i interakcije lijekova. In Francetić I, Vitezić D (eds): Osnove kliničke farmakologije, 147-164, Madicinska naklada, Zagreb, 2007.
8. Gentle S: Long-term treatment with atypical antipsychotics and the risk of weight gain: a literature analysis. Drug Safety 2006; 29:303-319
9. Gorman J M: The Essential Guide to Psychiatric Drugs. Revised and Updated Fourth Edition. St. Martin's Griffin, New York, 2007.
10. Healy D: Psychiatric Drugs Explained. Fourth edition. Elsevier Churchill Liwingstone, Edinburgh, 2005.
11. Hoehn-Saric R, Lipsey JR, McLeod DR: Apathy and indifference in patients on fluvoxamine and fluoxetine. Journal of Clinical Psychopharmacology 1990; 10:343-345 (Pubitemid 20378677)
12. Hudson TJ, Owen RR, Trush CR, Han X, Pyne JM, Thapa P & Sullivan G: A pilot study of barriers to medication adherence in schizophrenia. Journal of Clinical Psychiatry, 2004; 65:211-216
13. Huić M: Nuspojave lijekova i medicinskih proizvoda. In Vrhovac B, and others: Farmakoterapijski priručnik. fifth edition, 15-17, Medicinska naklada, Zagreb, 2007.
14. Jakovljević M: Contemporary psychopharmacotherapy in the context of brave new psychiatry, well-being therapy and life coaching. Psychiatria Danubina 2007; 19:195-201.
15. Jakovljević M: The side effects of psychopharmacotherapy: Conceptual, explanatory, ethical and moral issues - creative psychopharmacology instead of toxic psychiatry. Psychiatria Danubina 2009; 21:81-90.
16. Jakovljević M: Transdisciplinary holistic integrative psychiatry - A wishful thinking or reality? Psychiatria Danubina 2008; 20:341-348.
17. Keshavan MS: Principles of drug therapy in psychiatry - How to do the least harm. In Keshavan MS & Kennedy JS (eds): Drug-induced dysfunction in Psychiatry, 3-8. Hemisphere Publishing Corporation, New York, 1992.
18. Lambert TJR, Castle DJ. Pharmacological approaches to the management of schizophrenia. Med J Aust 2003; 178:57-61 (suppl 5).
19. Lawson WB: Issues in Pharmacotherapy for African Americans. In Ruiz P (ed): Ethnicity and Psychopharmacology. American Psychiatric Press, Inc. Washington, 2000.
20. Lee A, Rawlins M D: Nuspojave lijekova. In Walker R and Edwards C (eds): Klinicka farmacija i terapija, 33-46. Školska knjiga, Zagreb, 2004.
21. Liberman JA, III: Managing Anticholinergic Side Effects. The Primary Care Companion 2004; 6:20-23 (suppl 2).
22. Novak L, Švab V: Antipsychotics side effect influence on stigma of mental illness: focus group study results. Psychiatria Danubina 2009; 21:99-102.
23. Preston JD, O'Neal JH, Talaga MC, Handbook of Clinical Psychopharmacology for Therapists. fifth edition. 267-269 New Harbinger Publications, Inc. Oakland, 2007.
24. Stein DJ: Philosophy of Psychopharmacology. Cambridge University Press, Cambridge, 2008.
25. Sussman N: General Principles of Psychopharmacology. In Sadock BJ & Sadock VA (eds): Kaplan & Sadock's Comprehensive Textbook of Psychiatry. eighth edition, vol two, 2676-2699, Lippincot Williams & Wilkins, Philadelphia, 2005.
26. Usher K, Foster K, Bullock S: Psychopharmacology for Health Professionals. Elsevier Australia, Sydney, 2009.
27. Uzun S, Kozumplik O, Mimica N, Folnegović-Šmalc V: Nuspojave psihofarmaka. Medicinska naklada, Psihijatrijska bolnica Vrapče, Zagreb, 2005.
28. Woods JH, Katz JL & Winger G: Use and abuse of benzodiazepines: issues relevant to prescribing. Journal of American Medical Association 1998; 260:3479-3480